Your browser is no longer supported. Please, upgrade your browser.
ECYT Endocyte, Inc. monthly Stock Chart
ECYT [NASD]
Endocyte, Inc.
Index- P/E- EPS (ttm)-0.68 Insider Own1.50% Shs Outstand82.16M Perf Week0.04%
Market Cap1.96B Forward P/E- EPS next Y-0.68 Insider Trans-8.57% Shs Float78.40M Perf Month1.10%
Income-41.30M PEG- EPS next Q-0.16 Inst Own79.70% Short Float10.64% Perf Quarter29.78%
Sales0.10M P/S19586.94 EPS this Y-20.60% Inst Trans16.90% Short Ratio2.94 Perf Half Y66.02%
Book/sh4.82 P/B4.95 EPS next Y- ROA-20.50% Target Price24.33 Perf Year407.23%
Cash/sh4.19 P/C5.69 EPS next 5Y- ROE-21.20% 52W Range2.81 - 23.94 Perf YTD457.01%
Dividend- P/FCF- EPS past 5Y-21.10% ROI- 52W High-0.42% Beta0.09
Dividend %- Quick Ratio45.80 Sales past 5Y- Gross Margin- 52W Low748.40% ATR0.12
Employees44 Current Ratio45.80 Sales Q/Q164.20% Oper. Margin- RSI (14)81.10 Volatility0.23% 0.42%
OptionableYes Debt/Eq0.00 EPS Q/Q67.90% Profit Margin- Rel Volume0.52 Prev Close23.86
ShortableYes LT Debt/Eq0.00 EarningsNov 05 Payout- Avg Volume2.84M Price23.84
Recom2.30 SMA200.65% SMA508.99% SMA20051.02% Volume1,471,584 Change-0.08%
Apr-13-18Initiated Jefferies Buy $17
Mar-09-18Initiated Wells Fargo Outperform $20
Oct-03-17Upgrade Wedbush Neutral → Outperform $2 → $7
Jun-05-17Downgrade Wedbush Outperform → Neutral $8 → $2
Mar-03-16Reiterated Wedbush Outperform $12 → $8
Jan-21-16Initiated Credit Suisse Outperform
Nov-04-15Reiterated RBC Capital Mkts Outperform $13 → $10
Aug-05-15Reiterated RBC Capital Mkts Outperform $15 → $13
Sep-30-14Downgrade Brean Capital Buy → Hold
Jul-08-14Resumed Brean Capital Buy $22
Jun-18-14Reiterated RBC Capital Mkts Outperform $20 → $15
Jun-18-14Reiterated Chardan Capital Markets Buy $26 → $15
May-05-14Reiterated RBC Capital Mkts Outperform $46 → $20
May-05-14Reiterated Chardan Capital Markets Buy $43 → $26
May-02-14Reiterated Brean Capital Buy $41 → $22
May-02-14Downgrade Robert W. Baird Outperform → Neutral $36 → $8
Mar-25-14Reiterated Chardan Capital Markets Buy $20 → $43
Mar-21-14Reiterated Brean Capital Buy $21 → $41
Sep-30-13Initiated Chardan Capital Markets Buy $20
Mar-25-13Upgrade Robert W. Baird Neutral → Outperform $9 → $13
Dec-08-18 12:50PM  Do Hedge Funds Love Endocyte, Inc. (ECYT)? Insider Monkey
Nov-16-18 06:05PM  Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Endocyte, Inc. In The U.S. District Court For The Southern District Of New York PR Newswire
Nov-09-18 08:55AM  Recent Analysis Shows Audentes Therapeutics, Endocyte, Bluerock Residential Growth REIT, Air Products and Chemicals, BWX Technologies, and Modine Manufacturing Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-07-18 06:50PM  Endocyte (ECYT) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:44PM  Endocyte: 3Q Earnings Snapshot Associated Press
04:01PM  Endocyte Provides Third Quarter 2018 Financial Results and Operational Update GlobeNewswire
Nov-02-18 05:08AM  Bayer CEO backs group's diversified structure Reuters
Nov-01-18 11:53PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Endocyte, Inc. - ECYT PR Newswire
Oct-26-18 09:51AM  Zacks.com featured highlights include: Lamb Weston, Dollar General, Endocyte and CONSOL Zacks
Oct-22-18 08:08AM  This tiny biotech spun a quick $2 billion from $12 million MarketWatch
Oct-19-18 10:41AM  Can The Uptrend Continue for Endocyte (ECYT)? Zacks
08:28AM  The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut Benzinga
08:00AM  Todays Research Reports on Stocks to Watch: Proteostasis Therapeutics and Endocyte ACCESSWIRE
Oct-18-18 07:46PM  [$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion The Wall Street Journal +50.39%
04:11PM  Stocks plunge, Dow falls 327 points Yahoo Finance
02:58PM  Endocyte's $2.1 Billion Deal Rewards Investors Who Stuck It Out Bloomberg
01:30PM  Novartis to Buy Biopharmaceutical Company Endocyte for $2.1 Billion GuruFocus.com
11:55AM  Dow Takes Sharp Turn Lower on Rates Fears, Tech Shares Sink TheStreet.com
11:06AM  [$$] These Guys Should Start a Hedge Fund The Wall Street Journal
11:06AM  Novartis buying cancer drug maker Endocyte for $2.1B Yahoo Finance Video
09:41AM  Novartis Gets Key Therapy -- For Almost 200 Times Its Last Price Bloomberg
09:35AM  Why Endocyte, Inc. Stock Is Soaring Today Motley Fool
09:16AM  Novartis Secures Prostate Cancer Treatment With Endocyte Deal TheStreet.com
09:06AM  Novartis To Buy Endocyte In $2.1B Deal Benzinga
08:20AM  [$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion The Wall Street Journal
07:56AM  The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Benzinga
07:54AM  Stocks making the biggest move premarket: TRV, BX, BK, DHR, TXT, PM & more CNBC
07:24AM  Endocyte stock pops 50% on $2.1 bln Novartis acquisition MarketWatch
07:17AM  Facebook, Fed Minutes, AmEx, PayPal and Endocyte - 5 Things You Must Know TheStreet.com
06:24AM  [$$] European Equities Market Talk Roundup The Wall Street Journal
05:06AM  Novartis pushes deeper into nuclear medicine with $2.1 billion deal Reuters
05:00AM  Novartis pushes deeper into nuclear medicine with $2.1 bln deal Reuters
03:39AM  Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share Benzinga
02:58AM  Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash Reuters
02:28AM  Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash Reuters
01:50AM  Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate Reuters
01:29AM  Novartis to buy Endocyte for $2.1 billion in cash Reuters
01:10AM  Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion GlobeNewswire
Oct-10-18 08:35AM  New Research Coverage Highlights Endocyte, Power Integrations, Caterpillar, PROS, Ingevity, and SunCoke Energy Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-09-18 08:14AM  Do Institutions Own Shares In Endocyte Inc (NASDAQ:ECYT)? Simply Wall St.
Oct-03-18 06:00AM  Endocyte becomes first Purdue startup to reach $1.5B in value GlobeNewswire
Sep-27-18 08:01AM  Endocyte to Present at Two Investor Conferences on October 2nd GlobeNewswire
Sep-14-18 04:01PM  Endocyte Announces Closing of Public Offering of Common Stock GlobeNewswire
09:43AM  Pharma/Biotech Stocks to Watch This Prostate Cancer Month Zacks
Sep-12-18 08:26AM  The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead's Rheumatoid Arthritis Drug, Bausch Health Trims Debt Benzinga
Sep-11-18 07:53PM  Endocyte Announces Pricing of Public Offering of Common Stock GlobeNewswire
11:37AM  Endocyte Announces FDA's Acceptance of Trial Endpoint Change Zacks
10:13AM  Company News For Sep 11, 2018 Zacks
08:55AM  Endocyte (ECYT) Soars: Stock Adds 11.4% in Session Zacks
08:25AM  The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Amgen and Endocyte ACCESSWIRE
06:30AM  3 Surging Biotech Stocks -- Can They Keep Climbing? Motley Fool
Sep-10-18 04:58PM  After-hours buzz: SONO, NTNX & more CNBC +11.38%
04:53PM  Here's Why Endocyte Jumped Higher Today and Is Down After Hours Motley Fool
04:15PM  Endocyte Announces $175.0 Million Proposed Public Offering of Common Stock GlobeNewswire
08:00AM  Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS) GlobeNewswire
Sep-07-18 08:48AM  Is the Options Market Predicting a Spike in Endocyte (ECYT) Stock? Zacks
Aug-30-18 11:26AM  Endocyte (ECYT) Up 14.6% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-18 08:01AM  Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference GlobeNewswire -5.95%
Aug-28-18 05:04PM  UPDATE - Endocyte Announces Presentations at the CAR-TCR Summit 2018 GlobeNewswire
04:01PM  Endocyte Announces Presentations at the CAR-TCR Summit 2018 GlobeNewswire
Aug-17-18 08:30AM  Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition GlobeNewswire +5.16%
Aug-08-18 08:01AM  Endocyte to Present at the 2018 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-03-18 08:30AM  Recent Analysis Shows Eaton Vance, Endocyte, Ion Geophysical, Macerich, SunCoke Energy, and Dolby Laboratories Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -5.40%
Aug-02-18 07:14AM  Edited Transcript of ECYT earnings conference call or presentation 31-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-01-18 10:09AM  Endocyte (ECYT) Posts Narrower-Than-Expected Loss in Q2 Zacks +6.27%
Jul-31-18 09:48AM  Endocyte (ECYT) Posts Narrower than Expected Loss in Q2 Zacks
09:08AM  Endocyte: 2Q Earnings Snapshot Associated Press
08:01AM  Endocyte Provides Second Quarter 2018 Financial Results and Operational Update GlobeNewswire
06:30AM  Endocyte, Inc. to Host Earnings Call ACCESSWIRE
Jul-30-18 09:49AM  Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT Zacks
Jul-27-18 10:10AM  Is a Beat in Store for Endocyte (ECYT) This Earnings Season? Zacks
Jul-25-18 08:01AM  Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call GlobeNewswire
Jul-24-18 07:55AM  Free Research Reports on CorMedix and Three More Biotech Stocks ACCESSWIRE -7.24%
Jul-20-18 09:30AM  Has Endocyte (ECYT) Outpaced Other Medical Stocks This Year? Zacks
Jul-18-18 07:30AM  The Market That Took BEAT Higher By 800% Could Do The Same For This Strong New Competitor ACCESSWIRE
Jul-14-18 07:16AM  The 4 Best Biotech Stocks of 2018 (So Far) Motley Fool
Jul-11-18 09:15AM  3 Huge Biotech Winners in 2018 (So Far) Motley Fool
Jul-09-18 08:00AM  Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177 GlobeNewswire
Jul-02-18 03:06PM  4 Biotech Stocks That Tripled in the First Half of 2018 Motley Fool
Jun-28-18 06:33AM  The 3 Best Biotech Stocks of 2018 So Far Motley Fool
Jun-27-18 12:03PM  Harry Boxers four momentum stocks breaking out MarketWatch
Jun-26-18 07:00PM  Image Following Treatment with 177Lu-PSMA-617 Selected by Society of Nuclear Medicine and Molecular Imaging as Image of the Year GlobeNewswire +5.94%
Jun-25-18 08:01AM  Endocyte to Join the Russell 3000® Index GlobeNewswire
Jun-22-18 08:01AM  Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting GlobeNewswire
Jun-21-18 08:07AM  3 Soaring Biotech Stocks. Can They Keep Climbing? Motley Fool
Jun-08-18 10:37AM  Endocyte (ECYT) Up 5.1% Since Earnings Report: Can It Continue? Zacks +5.65%
Jun-05-18 08:01AM  Endocyte Announces Enrollment of First Patient in Phase 3 VISION Trial of 177Lu-PSMA-617 in Prostate Cancer GlobeNewswire
May-30-18 12:21PM  Marijuana Stock Among Four Moving Higher Forbes
12:14PM  Harry Boxers five momentum stocks to watch, including Canopy Growth and Impinj MarketWatch
May-29-18 04:30PM  Endocyte to Present at Jefferies Healthcare Conference GlobeNewswire
May-18-18 04:51PM  Winners and Losers From the Biggest Cancer Meeting of the Year (So Far) Motley Fool +6.96%
07:50AM  Blog Exposure - FDA Accepted for Review Insmeds Marketing Application for ALIS in NTM Lung Disease Caused by MAC ACCESSWIRE
May-17-18 12:19PM  Should You Be Concerned With Endocyte Incs (NASDAQ:ECYT) -15.38% Earnings Drop? Simply Wall St. +7.56%
May-16-18 06:05PM  Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
May-12-18 11:53AM  These 5 Nasdaq Stocks Broke Out & Hit New 52-Week Highs Last Week Forbes
03:41AM  Edited Transcript of ECYT earnings conference call or presentation 9-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-11-18 05:59AM  Endocyte (ECYT) Q1 Loss Narrower Than Expected, Shares Up Zacks
May-10-18 01:27PM  Four momentum stocks to watch amid earnings reports MarketWatch
May-09-18 09:30AM  Endocyte (ECYT) Posts Narrower than Expected Loss in Q1 Zacks +8.60%
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer. The company's products in pre-clinical development include EC2629, a folate receptor-targeted SMDC for use in treating cancer; EC2319 for the treatment of inflammatory diseases; EC0371 for treating polycystic kidney disease; and SMDC bi-specific adaptor chimeric antigen receptor T-cell for the treatment of immunotherapy in cancer. Endocyte, Inc. has a collaboration agreement with Purdue Research Foundation; Master License Agreement with Purdue Research Foundation; Merck Sharp & Dohme Research GmbH; and Nihon Medi-Physic Co., LTD. The company was founded in 1995 and is headquartered in West Lafayette, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andriole Michael T.Chief Financial OfficerOct 09Sale15.8563510,065132,082Oct 09 02:16 PM
Leamon Christopher PVice President of ResearchOct 05Sale15.569,028140,437121,353Oct 09 02:20 PM
Armour Alison A.Chief Medical OfficerOct 05Sale15.569,111141,748101,040Oct 09 02:21 PM
Taylor BethVP Finance & Chief Acctg OffcrOct 05Sale15.567,022109,28756,341Oct 09 02:20 PM
Sherman Michael A.President and CEOOct 05Sale15.5528,146437,752347,918Oct 09 02:18 PM
Andriole Michael T.Chief Financial OfficerOct 05Sale15.5517,283268,783132,717Oct 09 02:16 PM
Parker KatherineVP of Human ResourcesOct 05Sale15.556,771105,31670,349Oct 09 02:14 PM
Chelius Erik C.Vice President CMCOct 05Sale15.564,51470,24349,895Oct 09 02:16 PM
Low Philip SChief Science OfficerOct 05Sale15.565,92892,238319,817Oct 09 02:14 PM
Leamon Christopher PVice President of ResearchAug 29Option Exercise2.544,69611,928135,077Aug 29 05:20 PM
Leamon Christopher PVice President of ResearchAug 29Sale20.004,69693,920130,381Aug 29 05:20 PM
Leamon Christopher PVice President of ResearchAug 28Option Exercise2.5412,67032,182143,051Aug 29 05:20 PM
Taylor BethVP Finance & Chief Acctg OffcrAug 28Sale20.007,892157,84063,363Aug 29 02:51 PM
Leamon Christopher PVice President of ResearchAug 28Sale20.0012,670253,403130,381Aug 29 05:20 PM
Taylor BethVP Finance & Chief Acctg OffcrAug 20Sale18.202855,18771,255Aug 22 10:29 AM
Armour Alison A.Chief Medical OfficerAug 01Sale15.981,41422,589110,151Aug 02 04:05 PM
Leamon Christopher PVice President of ResearchJun 12Sale15.0613,089197,058130,381Jun 13 03:30 PM
Leamon Christopher PVice President of ResearchMar 09Sale9.075,03645,677143,470Mar 12 01:33 PM
Sherman Michael A.President and CEOFeb 02Option Exercise3.065,45316,686338,564Feb 06 12:01 PM
Low Philip SChief Science OfficerDec 28Option Exercise3.0665,445200,262354,050Jan 02 03:39 PM
Low Philip SChief Science OfficerDec 28Sale4.4150,511222,824303,539Jan 02 03:39 PM